Viking Therapeutics, Inc.
Key Metrics
Market Snapshot
About
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel therapies for metabolic and endocrine disorders. The company's pipeline includes drug candidates for non-alcoholic steatohepatitis (NASH), obesity, type 2 diabetes, and other metabolic conditions. Viking focuses on small molecule therapeutics targeting nuclear receptors.